Ciproflox-dexameth otic susp 7.5ML
Ended Awarded
- Contract number
- SPE2DB25FSBEK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,402
Award facts
- Contract value 100% obligated
- $3,401.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,401.76 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract employs firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency encompasses a broad spectrum of pharmaceutical products, medical supplies, brand-name and generic medications, vaccines, and specialized healthcare commodities. The DLA Troop Support Medical IDC enables AmerisourceBergen to fulfill pharmaceutical needs across multiple therapeutic domains in support of military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for the ophthalmic antibiotic-corticosteroid combination represents a routine procurement transaction within the broader framework of the contractor's substantial federal medical supply capabilities.
Quick answers
Who was awarded contract SPE2DB25FSBEK?
SPE2DB25FSBEK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FSBEK worth?
The government has obligated $3,402 on SPE2DB25FSBEK.
Is contract SPE2DB25FSBEK an order under another contract?
Yes. SPE2DB25FSBEK is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSBEK competed?
The extent of competition for SPE2DB25FSBEK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award